Does HCV treatment completion affect the neurocognitive outcomes in patients on opioid agonist maintenance treatment: A secondary analysis.

IF 1.7 4区 医学 Q3 PSYCHIATRY
Abhishek Ghosh, Abhishek Verma, Arka De, Madhumita Premkumar, Ajay Duseja, Ritu Nehra, Debasish Basu
{"title":"Does HCV treatment completion affect the neurocognitive outcomes in patients on opioid agonist maintenance treatment: A secondary analysis.","authors":"Abhishek Ghosh, Abhishek Verma, Arka De, Madhumita Premkumar, Ajay Duseja, Ritu Nehra, Debasish Basu","doi":"10.4103/indianjpsychiatry.indianjpsychiatry_900_24","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>This secondary analysis investigated whether completing Direct-Acting Antiviral (DAA) treatment affects neurocognitive outcomes in patients with opioid use disorder (OUD) undergoing opioid agonist maintenance treatment (OAMT).</p><p><strong>Methods: </strong>Data from 45 participants (22 DAA treatment completers and 23 non-completers) were analyzed. Neurocognitive function was assessed at baseline and six months using the Wisconsin Card Sorting Test (WCST), Trail Making Tests (TMT A and B), Visual and Verbal N-Back tests, and Iowa Gambling Task (IGT).</p><p><strong>Results: </strong>General Linear Model (GLM) analysis revealed significant improvements in cognitive function over time in both groups, with notable gains in WCST total correct responses (<i>P</i> < .001) and Visual Working Memory 2 Back hits and errors (<i>P</i> < .001). A significant Group × Time was found for TMT-B completion time, with non-completers showing greater improvement (<i>P</i> = .039).</p><p><strong>Conclusion: </strong>These findings highlight that even incomplete DAA treatment, alongside OAMT, yields significant cognitive benefits, underscoring the importance of integrated care.</p>","PeriodicalId":13345,"journal":{"name":"Indian Journal of Psychiatry","volume":"67 2","pages":"260-266"},"PeriodicalIF":1.7000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11964169/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_900_24","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/19 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: This secondary analysis investigated whether completing Direct-Acting Antiviral (DAA) treatment affects neurocognitive outcomes in patients with opioid use disorder (OUD) undergoing opioid agonist maintenance treatment (OAMT).

Methods: Data from 45 participants (22 DAA treatment completers and 23 non-completers) were analyzed. Neurocognitive function was assessed at baseline and six months using the Wisconsin Card Sorting Test (WCST), Trail Making Tests (TMT A and B), Visual and Verbal N-Back tests, and Iowa Gambling Task (IGT).

Results: General Linear Model (GLM) analysis revealed significant improvements in cognitive function over time in both groups, with notable gains in WCST total correct responses (P < .001) and Visual Working Memory 2 Back hits and errors (P < .001). A significant Group × Time was found for TMT-B completion time, with non-completers showing greater improvement (P = .039).

Conclusion: These findings highlight that even incomplete DAA treatment, alongside OAMT, yields significant cognitive benefits, underscoring the importance of integrated care.

HCV治疗完成是否会影响阿片类激动剂维持治疗患者的神经认知结局:一项次要分析。
目的:这项二次分析调查了完成直接作用抗病毒药物(DAA)治疗是否会影响接受阿片激动剂维持治疗(OAMT)的阿片类药物使用障碍(OUD)患者的神经认知结果:分析了45名参与者(22名完成DAA治疗者和23名未完成治疗者)的数据。在基线和6个月时,使用威斯康星卡片分类测试(WCST)、路径制作测试(TMT A和B)、视觉和言语N-Back测试以及爱荷华赌博任务(IGT)对神经认知功能进行评估:通用线性模型(GLM)分析表明,随着时间的推移,两组患者的认知功能都有显著改善,其中 WCST 总正确率(P < .001)和视觉工作记忆 2 回的命中率和错误率(P < .001)显著提高。在 TMT-B 完成时间方面,发现了明显的组别 × 时间关系,未完成者的进步更大(P = .039):这些研究结果表明,即使是不完全的 DAA 治疗,与 OAMT 同时进行,也能产生显著的认知益处,从而强调了综合护理的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Indian Journal of Psychiatry
Indian Journal of Psychiatry Medicine-Psychiatry and Mental Health
CiteScore
4.40
自引率
3.20%
发文量
130
审稿时长
34 weeks
期刊介绍: The Indian Journal of Psychiatry (ISSN 0019-5545), is an official publication of the Indian Psychiatric Society. It is published Bimonthly with one additional supplement (total 5 issues). The IJP publishes original work in all the fields of psychiatry. All papers are peer-reviewed before publication. The issues are published Bimonthly. An additional supplement is also published annually. Articles can be submitted online from www.journalonweb.com . The journal provides immediate free access to all the published articles. The journal does not charge the authors for submission, processing or publication of the articles.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信